Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

259
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

304
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

223
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

564
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
564
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.5K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Pharmacological activation of NO-cGMP signalling attenuates metabolic dysfunction-associated steatohepatitis.

British journal of pharmacology·2026
Same author

Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report.

Leukemia·2026
Same author

Loss of systemic anti-viral immunity and LMP1-driven suppressive myeloid tumour niches converge to shape the immunobiology of Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Leukemia·2026
Same author

Noninvasive in vivo imaging of NF-κB activation predicts immunotherapy response in solid tumors.

Npj imaging·2026
Same author

DNA methylation-based classification of hematolymphoid neoplasms.

Blood advances·2026
Same author

Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model.

Neoplasia (New York, N.Y.)·2026

関連する実験動画

Updated: Jan 31, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.5K

小児リンパ腫の診断上の課題

Jan Bosch-Schips1,2, Leticia Quintanilla-Martinez1,3, Falko Fend4

  • 1Institut für Pathologie und Neuropathologie und Referenzzentrum für Hämatopathologie, Universitätsklinikum Tübingen, Liebermeisterstraße 8, 72076, Tübingen, Deutschland.

Pathologie (Heidelberg, Germany)
|January 29, 2026
PubMed
まとめ
この要約は機械生成です。

小児リンパ腫はまれであり、成人型とは異なります。このレビューでは、それらの分類、生物学、および診断をカバーし、正確な特定のためにまれな無緩徐型およびリンパ腫模倣に焦点を当てています。

キーワード:
IRF4再構成型大細胞型B細胞リンパ腫無緩徐型B細胞リンパ腫リンパ腫模倣反応性増殖小児濾胞性リンパ腫小児リンパ腫

さらに関連する動画

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry
03:37

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry

Published on: June 6, 2025

463
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.8K

関連する実験動画

Last Updated: Jan 31, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.5K
Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry
03:37

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry

Published on: June 6, 2025

463
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.8K

科学分野:

  • 小児血液腫瘍学;腫瘍生物学;診断病理学

背景:

  • 小児リンパ腫は、すべてのリンパ腫のわずかな割合を占め、成人例と比較して、特有のサブタイプ分布、分子特性、および予後を示します。小児リンパ腫の異質性と、悪性腫瘍を模倣する反応性リンパ増殖の存在により、正確な分類と診断が不可欠です。

研究 の 目的:

  • 小児リンパ腫の分類、生物学、および診断における現在の進歩をレビューすること。小児および青年におけるリンパ腫を模倣するまれな無緩徐型サブタイプおよび反応性病変に焦点を当てること。

主な方法:

  • 小児リンパ腫に関する包括的な文献レビュー。WHO小児腫瘍分類を含む、分類システムの最近の更新の分析。診断上の課題、鑑別診断、および特定の病変についての議論。

主要な成果:

  • 一般的な小児リンパ腫には、バーキットリンパ腫、リンパ芽球性リンパ腫、ホジキンリンパ腫、ALK陽性未分化大細胞リンパ腫が含まれます。小児型濾胞性リンパ腫や小児型節性辺縁帯リンパ腫などのまれな無緩徐型サブタイプは、良好な予後を示します。IRF4再構成型大細胞型B細胞リンパ腫や11q異常を伴う高悪性度/大細胞型B細胞リンパ腫などの悪性サブタイプも、良好な転帰を示します。感染性単核球症、Kikuchi-Fujimoto病などの反応性リンパ増殖は、診断上の課題をもたらします。

結論:

  • 小児リンパ腫は、臨床的および生物学的に異なる特徴を持つ異種性のグループです。正確な診断には、まれな無緩徐型病変、新たに定義された大細胞型B細胞リンパ腫、および反応性模倣の慎重な鑑別が必要です。最近の分類では、これらの小児リンパ腫特有の側面がますます取り入れられています。